Clinical EvaluationsThe VibraJect's ability to assist in the reduction of pain perceived by the patient was assessed by qualified dentists in a randomized controlled clinical trial at Queen's University Belfast, N. Ireland. The study involved 329 patients and it was found that by using the VibraJect, patient's perception of pain was reduced. This was statistically highly significant, indicating less painful injections for patients, especially in the most painful areas, whereas in this particular study, topical anesthetic did not. The involved dentists gave positive feedback such as its ease of use, efficiency, and its non-invasiveness. Overall, it was deemed to be a useful tool in the quest to improve dentist-patient rapport. For a copy of the poster presentation of these results presented at the 2004 meeting of the AIDR in Honolulu, click here.Other Evaluations
|
